atropine has been researched along with nalbuphine in 6 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (nalbuphine) | Trials (nalbuphine) | Recent Studies (post-2010) (nalbuphine) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 793 | 269 | 185 |
Protein | Taxonomy | atropine (IC50) | nalbuphine (IC50) |
---|---|---|---|
Mu-type opioid receptor | Homo sapiens (human) | 0.0578 | |
Delta-type opioid receptor | Homo sapiens (human) | 1.1195 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.097 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hanig, JP; Hui, FW; Sun, CJ; Tocus, EC | 1 |
Bakhshandeh, M; Bjorksten, AR; Doufas, AG; Greif, R; Laciny, S; Larson, MD; Mokhtarani, M; Rajek, AM; Sessler, DI | 1 |
1 review(s) available for atropine and nalbuphine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for atropine and nalbuphine
Article | Year |
---|---|
Neither nalbuphine nor atropine possess special antishivering activity.
Topics: Adult; Analgesics, Opioid; Atropine; Body Temperature; Cold Temperature; Conscious Sedation; Dose-Response Relationship, Drug; Heart Rate; Humans; Injections, Intravenous; Male; Muscarinic Antagonists; Nalbuphine; Oxygen Consumption; Oxyhemoglobins; Pupil; Respiratory Mechanics; Shivering; Vomiting | 2001 |
4 other study(ies) available for atropine and nalbuphine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
The effect of tripelennamine alone and in combination with opiates to produce antinociception in mice.
Topics: Analgesia; Animals; Atropine; Dose-Response Relationship, Drug; Drug Interactions; Histamine; Male; Mice; Morphine; Nalbuphine; Naloxone; Narcotics; Tripelennamine | 1983 |